The Psychomotor Retardation, a Marker of Response to rTMS Treatment in Patients with Major Depressive Disorder? - Nantes Université Accéder directement au contenu
Article Dans Une Revue Neuropsychiatry Année : 2017

The Psychomotor Retardation, a Marker of Response to rTMS Treatment in Patients with Major Depressive Disorder?

Résumé

Now more than ever, let us continue to develop personalized medicine to improve the remission rate for treatment resistant depressed patients. Recent findings about psychomotor retardation-a core symptom of depression-provide new insights into the predictive efficiency of personalized treatments, such as rTMS.
Fichier principal
Vignette du fichier
Deschamps et al (2017)_The Psychomotor Retardation, a Marker of Response to rTMS Treatment in Patients with Major Depressive Disorder.pdf (112.06 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03340120 , version 1 (10-09-2021)

Identifiants

Citer

Thibault Deschamps, Anne Sauvaget, Samuel Bulteau, Véronique Thomas-Ollivier. The Psychomotor Retardation, a Marker of Response to rTMS Treatment in Patients with Major Depressive Disorder?. Neuropsychiatry, 2017, 07, ⟨10.4172/neuropsychiatry.1000274⟩. ⟨hal-03340120⟩
44 Consultations
61 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More